Subsequent research on patients carrying the RBM20 mutations confirmed that DCM symptoms manifested themselves at an early age, followed by a high degree of morbidity and mortality even in young children due to the deterioration of cardiac systolic function toward end-stage heart failure [30, 51, 52]. This evidence concerns the gene RBM20 and familial dilated cardiomyopathy.